Literature DB >> 23906877

Surgery for rheumatic valve disease in pregnancy: what about the newborn?

Cemal Levent Birincioglu1, Ertekin Utku Unal2, Istemi Han Celik3, Anil Ozen1, Sercan Tak1, Aysen Aksoyek1, Omer Erdeve4, Ugur Dilmen5.   

Abstract

BACKGROUND: Valvular heart disease constitutes the majority of all causes of cardiac disease in pregnancy. The significant physiological haemodynamic changes of pregnancy may cause serious cardiac problems leading to severe maternal and foetal morbidity and mortality. In this study, we evaluate the effect of maternal rheumatic valvular disease requiring definitive operation concurrent with caesarian delivery on maternal and foetal outcome.
METHODS: Between 2003 and 2010, a total of nine pregnant women and nine live births were examined. Immediately after caesarean section, the newborns were examined by the neonatologist and transferred to the neonatal intensive care unit. All the mothers were followed routinely with clinical and echocardiographic examinations.
RESULTS: The age at the time of delivery ranged between 21 and 36 years (median 31 years). Postoperative period of mothers was uneventful and mean hospital stay was 7.56±3.97 days. Birth weight for the newborns was ranged between 1370 and 2900g. Six of the newborns were premature (≤37 weeks). Four newborns were small for gestational age (SGA). There was no mortality in newborns. Hospital stay for the newborns ranged between four and 54 days.
CONCLUSIONS: Careful follow-up of pregnancies with valvular heart diseases and determining the optimal time of cardiac intervention are the essential issues. We suggest that careful follow-up of both mother and foetus until at least the 28th gestational week, following which combined caesarian section and cardiac surgery can be performed.
Copyright © 2013 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiac surgery; Newborn; Outcome; Pregnancy; Valvular heart disease

Mesh:

Year:  2013        PMID: 23906877     DOI: 10.1016/j.hlc.2013.05.639

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  3 in total

Review 1.  The Pan-African Society of Cardiology position paper on reproductive healthcare for women with rheumatic heart disease.

Authors:  Ana Olga Mocumbi; Keila K Jamal; Amam Mbakwem; Maylene Shung-King; Karen Sliwa
Journal:  Cardiovasc J Afr       Date:  2018-09-18       Impact factor: 0.802

2.  A Historic Case of Cardiac Surgery in Pregnancy.

Authors:  Said Benlamkaddem; Adnane Berdai; Smael Labib; Mustapha Harandou
Journal:  Case Rep Obstet Gynecol       Date:  2016-10-10

3.  Infective Endocarditis as a Complication of Intravenous Drug Use in Pregnancy: A Retrospective Case Series and Literature Review.

Authors:  Adebayo Adesomo; Veronica Gonzalez-Brown; Kara M Rood
Journal:  AJP Rep       Date:  2020-09-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.